多機能 OCT/OCTA/OCE 内視鏡による膣の健康状態の継続的な監視と管理
多機能 1.7um 光コヒーレンストモグラフィー/血管造影内視鏡検査による膣の健康の継続的な監視と管理
We have recently developed and optimized a vaginal Optical Coherence tomography/angiography endoscopy imaging system. This technology is able to obtain a comprehensive image of the vaginal epithelium, blood vessels, and lamina propria. The primary focus of this study is establishing the Optical Coherence Tomography system's capability of capturing vaginal changes that occur before and after menopause, as well as before and after treatment with fractional-CO2 laser therapy.
There are two aims of this study.
Aim 1:
1. To determine the feasibility and sensitivity of the integrated optical coherence endoscope to assess vaginal tissue integrity in pre, peri and postmenopausal women.
Aim 2:
To optically visualize the effects of fractional-CO2 laser treatment on vaginal tissue over the course of C02 vaginal laser therapy.
調査の概要
詳細な説明
The vaginal Optical Coherence tomography/angiography endoscopy imaging system. This technology is able to obtain a comprehensive image of the vaginal epithelium, blood vessels, and lamina propria. The primary focus of this study is establishing the Optical Coherence Tomography system's capability of capturing vaginal changes that occur before and after menopause, as well as before and after treatment with fractional-CO2 laser therapy.
There are two aims of this study.
Aim 1: To determine the feasibility and sensitivity of the integrated optical coherence endoscope to assess vaginal tissue integrity in pre, peri and postmenopausal women
We will enroll up to 90 women (age: 18 and older) who will be classified as pre-menopausal, peri- menopausal, or post-menopausal. There will be 30 women in each group. All enrolled subjects will first complete informed consents.
They will then fill out a questionnaire (the vulvovaginal symptom questionnaire) about their vaginal health. This will be followed by a pelvic exam to determine the vaginal health (vaginal health index) and to obtain a vaginal swab for assessment of the vaginal microbiome .
This will be followed by OCT scan of the vaginal tissue. There will be only one visit.
Aim 2: To optically visualize the effects of fractional-CO2 laser treatment on vaginal tissue over the course of C02 vaginal laser therapy.
Up to thirty Post-menopausal subjects with GSM who desire fractional-CO2 laser therapy, will be recruited.
Each visit will include: completion of a questionnaire (the vulvovaginal symptom questionnaire) about their vaginal health; followed by a pelvic exam to determine the vaginal health (vaginal health index) and to obtain a vaginal swab for assessment of the vaginal microbiome and an OCT scan of the vaginal tissue before the CO2 vaginal laser treatment.
This group will have a total of three visits with CO2 laser treatments. There will be a fourth visit which will include all the above study procedures except the CO2 laser treatment.
Subjects who complete 3 laser treatments will be offered participation in long term follow up with repeat OCT imaging every 3 months at 3, 6, 9 and 12 months after the final laser treatment to study the long- term effects of the laser treatment on the vaginal tissue.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究場所
-
-
California
-
Irvine、California、アメリカ、92612
- Beckman Laser Institute and Medical Clinic
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion criteria
Aim 1:
. Women who are premenopausal, peri-menopausal and postmenopausal
Aim 2:
. Postmenopausal women with genitourinary syndrome of menopause
Exclusion criteria
- history of pelvic irradiation
- Current pregnant or breastfeeding
- Use of hormone replacement therapy within three months of study enrollment
- Inability to read and understand english
- inability to follow research instructions
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:診断
- 割り当て:非ランダム化
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:CO2 Laser +OCT
Postmenopausal women with genitourinary syndrome of menopause who will receive CO2 vaginal laser treatment |
Fractional CO2 vaginal laser for genitourinary syndrome of menopause Optical coherence tomography endoscope |
|
実験的:OCT only
Premenopausal, peri-menopausal and postmenopausal women who will only get one time OCT scan |
Optical coherence tomography endoscope |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Vaginal epithelial thickness (VET)
時間枠:2 years
|
Vaginal epithelium thickness measured with the OCT. |
2 years
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
blood vessel density
時間枠:2 years
|
The blood vessel density will be measured by OCT |
2 years
|
|
Vaginal Health Index (VHI)
時間枠:2 years
|
VHI to be measured on exam |
2 years
|
|
Lactobacillus abundance
時間枠:2 years
|
Lactobacillus abundance by RNA sequencing |
2 years
|
協力者と研究者
捜査官
- 主任研究者:Felicia Lane, MD、UC Irvine
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 20195446
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。